advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (10)
Showing records 1 to 10
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation25462 Characteristics of respondents with glaucoma and dry eye in a national panel survey
Schmier J K; Covert D W
Clinical Ophthalmology 2009; 3: 645-650
25393 The effect of forskolin ophthalmic inserts on intraocular pressure in rabbit eyes
Wagh V D; Wagh K V; Inamdar B; Samanta M K
International Journal of Pharmacy and Pharmaceutical Sciences 2009; 146-155
25305 Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, thr
Sonty S; Mundorf T K; Stewart J A; Stewart W C
Clinical Therapeutics 2009; 31: 2063-2071
25328 Designing dendrimers for ocular drug delivery
Spataro G; Malecaze F; Turrin C -O; Soler V; Duhayon C; Elena P -P; Majoral J -P; Caminade A -M
European Journal of Medicinal Chemistry 2010; 45: 326-334
25239 The effect of lubricating eye drop containing hydroxypropyl guar on perimetry results of patients with glaucoma and trachomatous dry eye
Guzey M; Satici A; Karaman SK; Sezer S; Bozkurt O
Ophthalmologica 2010; 24: 109-115
25276 Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits
Afouna M I; Khedr A; Abdel-Naim A B; Al-Marzoqi A
Journal of Pharmaceutical Sciences 2010; 99: 119-127
25511 Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride
Ammar H O; Salama H A; Ghorab M; Mahmoud A A
AAPS PharmSciTech 2009; 10: 808-819
25512 Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy
Gupta S; Samanta M K; Raichur A M
AAPS PharmSciTech 2010; 1-14
25498 Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination
Rossi G C M; Pasinetti G M; Scudeller L; Tinelli C; Milano G; Bianchi P E
Expert Opinion in Pharmacotherapy 2010; 11: 499-504
25014 The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?
Somner JE; Cavanagh DJ; Wong KK; Whitelaw M; Thomson T; Mansfield D
Eye 2010; 24: 361-363
